Experienced in Endometrial Polyps

Dr. Michael W. Method

Gynecologic Oncology | Oncology
7979 N Shadeland Ave, Ste 310, 
Indianapolis, IN 
Experienced in Endometrial Polyps
7979 N Shadeland Ave, Ste 310, 
Indianapolis, IN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Method is a Gynecologic Oncologist and an Oncologist in Indianapolis, Indiana. Dr. Method is rated as an Experienced provider by MediFind in the treatment of Endometrial Polyps. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, and Lymphadenectomy.

His clinical research consists of co-authoring 26 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gynecologic Oncology
Oncology
Licenses
Obstetrics & Gynecology in MI
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D

Locations

7979 N Shadeland Ave, Ste 310, Indianapolis, IN 46250

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 2 Study of XL184 (Cabozantinib) in Recurrent or Metastatic Endometrial Cancer
A Phase 2 Study of XL184 (Cabozantinib) in Recurrent or Metastatic Endometrial Cancer
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Drug, Other
Study Drug: Cabozantinib S-malate
Study Phase: Phase 2
A Randomized Placebo-Controlled Phase II Trial Comparing Gemcitabine Monotherapy to Gemcitabine in Combination With AZD 1775 (MK 1775) in Women With Recurrent, Platinum Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers
A Randomized Placebo-Controlled Phase II Trial Comparing Gemcitabine Monotherapy to Gemcitabine in Combination With AZD 1775 (MK 1775) in Women With Recurrent, Platinum Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers
Enrollment Status: Active_not_recruiting
Publish Date: September 29, 2025
Intervention Type: Other, Drug
Study Drugs: Adavosertib, Gemcitabine hydrochloride
Study Phase: Phase 2
A Randomized Phase II/III Study to Assess the Efficacy of Trametinib (GSK 1120212) in Patients With Recurrent or Progressive Low-Grade Serous Ovarian Cancer or Peritoneal Cancer
A Randomized Phase II/III Study to Assess the Efficacy of Trametinib (GSK 1120212) in Patients With Recurrent or Progressive Low-Grade Serous Ovarian Cancer or Peritoneal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 13, 2025
Intervention Type: Other, Drug
Study Drugs: Letrozole, Paclitaxel, Pegylated liposomal doxorubicin hydrochloride, Tamoxifen citrate, Topotecan, Trametinib dimethyl sulfoxide
Study Phase: Phase 2/Phase 3
Phase II Study of the Levonorgestrel Intrauterine Device Alone or in Combination With the mTORC1 Inhibitor, Everolimus, for the Treatment of Complex Atypical Hyperplasia and Stage Ia Grade 1 Endometrial Cancer
Phase II Study of the Levonorgestrel Intrauterine Device Alone or in Combination With the mTORC1 Inhibitor, Everolimus, for the Treatment of Complex Atypical Hyperplasia and Stage Ia Grade 1 Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2025
Intervention Type: Device, Other, Drug
Study Drug: Everolimus
Study Phase: Phase 2
A Single Arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer
A Single Arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer
Enrollment Status: Completed
Publish Date: July 25, 2023
Intervention Type: Drug
Study Drug: Tisotumab Vedotin
Study Phase: Phase 2
A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic Neoplasia
A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic Neoplasia
Enrollment Status: Completed
Publish Date: August 12, 2022
Intervention Type: Other, Drug, Biological
Study Drugs: Dactinomycin, Leucovorin Calcium, Methotrexate
Study Phase: Phase 3
FORWARD I: A Randomized, Open Label Phase 3 Study to Evaluate the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) Versus Investigator's Choice of Chemotherapy in Women With Folate Receptor Alpha Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer
FORWARD I: A Randomized, Open Label Phase 3 Study to Evaluate the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) Versus Investigator's Choice of Chemotherapy in Women With Folate Receptor Alpha Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer
Enrollment Status: Completed
Publish Date: October 14, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

26 Total Publications

Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer.
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer.
Journal: Gynecologic oncology
Published: April 05, 2025
Similar Doctors
Advanced in Endometrial Polyps
Dr. Sarah K. Goodrich
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Advanced in Endometrial Polyps
Dr. Sarah K. Goodrich
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

St Vincent Physician Services Hospital And Health Care Center

8402 Harcourt Rd, 
Indianapolis, IN 
 (7.9 miles away)
317-415-6740
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sarah Goodrich is a Gynecologic Oncologist and an Oncologist in Indianapolis, Indiana. Dr. Goodrich has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Endometrial Polyps. Her top areas of expertise are Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Endometritis, and Oophorectomy. Dr. Goodrich is currently accepting new patients.

Advanced in Endometrial Polyps
Dr. James R. Dunlop
Gynecologic Oncology | Obstetrics and Gynecology
Advanced in Endometrial Polyps
Dr. James R. Dunlop
Gynecologic Oncology | Obstetrics and Gynecology

Seven Hills Ob-Gyn Associates LLC

1205 Hadley Rd, Suite 120, 
Mooresville, IN 
 (26.1 miles away)
317-584-3454
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

James Dunlop is a Gynecologic Oncologist and an Obstetrics and Gynecologist in Mooresville, Indiana. Dr. Dunlop is rated as an Advanced provider by MediFind in the treatment of Endometrial Polyps. His top areas of expertise are Ovarian Cysts, Neonatal Ovarian Cyst, Menorrhagia, Polycystic Ovary Syndrome, and Intrauterine Device Insertion. Dr. Dunlop is currently accepting new patients.

Experienced in Endometrial Polyps
Dr. Erin M. Lips
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Experienced in Endometrial Polyps
Dr. Erin M. Lips
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

University Obstetricians-Gynecologists,inc

535 Barnhill Dr, 
Indianapolis, IN 
 (11.1 miles away)
317-274-7879
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Erin Lips is a Gynecologic Oncologist and an Oncologist in Indianapolis, Indiana. Dr. Lips is rated as an Advanced provider by MediFind in the treatment of Endometrial Polyps. Her top areas of expertise are Lump in the Abdomen, Malignant Mixed Mullerian Tumor, Ovarian Cancer, Oophorectomy, and Vulvectomy. Dr. Lips is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Method's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile